Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery

CompletedOBSERVATIONAL
Enrollment

5,476

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2011

Conditions
Arthroplasty, ReplacementThromboembolism
Trial Locations (112)

Unknown

1160.85.4308 Boehringer Ingelheim Investigational Site, Graz

1160.85.4309 Boehringer Ingelheim Investigational Site, Klagenfurt

1160.85.4303 Boehringer Ingelheim Investigational Site, Linz

1160.85.4304 Boehringer Ingelheim Investigational Site, Linz

1160.85.4305 Boehringer Ingelheim Investigational Site, Saint Johann/Tirol

1160.85.4312 Boehringer Ingelheim Investigational Site, Stolzalpe

1160.85.4301 Boehringer Ingelheim Investigational Site, Vienna

1160.85.4302 Boehringer Ingelheim Investigational Site, Vienna

1160.85.4310 Boehringer Ingelheim Investigational Site, Vienna

1160.85.4311 Boehringer Ingelheim Investigational Site, Vienna

1160.85.4307 Boehringer Ingelheim Investigational Site, Wels

1160.85.3306A Boehringer Ingelheim Investigational Site, Angers

1160.85.3318A Boehringer Ingelheim Investigational Site, Bois Guillaume Cédex

1160.85.3333A Boehringer Ingelheim Investigational Site, Bordeaux

1160.85.3310A Boehringer Ingelheim Investigational Site, Caen

1160.85.3311A Boehringer Ingelheim Investigational Site, Clermont-Ferrand

1160.85.3315A Boehringer Ingelheim Investigational Site, Créteil

1160.85.3305A Boehringer Ingelheim Investigational Site, Dijon Cédex

1160.85.3304A Boehringer Ingelheim Investigational Site, Illkirch-Graffenstaden

1160.85.3334A Boehringer Ingelheim Investigational Site, Le Havre

1160.85.3324A Boehringer Ingelheim Investigational Site, Les Lilas

1160.85.3309A Boehringer Ingelheim Investigational Site, Lille

1160.85.3307A Boehringer Ingelheim Investigational Site, Lyon

1160.85.3325A Boehringer Ingelheim Investigational Site, Marseille

1160.85.3323A Boehringer Ingelheim Investigational Site, Metz

1160.85.3321A Boehringer Ingelheim Investigational Site, Nantes Cédex 2

1160.85.3301A Boehringer Ingelheim Investigational Site, Paris

1160.85.3302A Boehringer Ingelheim Investigational Site, Paris

1160.85.3303A Boehringer Ingelheim Investigational Site, Paris

1160.85.3320A Boehringer Ingelheim Investigational Site, Paris

1160.85.3308A Boehringer Ingelheim Investigational Site, Pierre-Bénite

1160.85.3322A Boehringer Ingelheim Investigational Site, Poitiers Cédex

1160.85.3319A Boehringer Ingelheim Investigational Site, Saint Etienne Cédex 2

1160.85.3317A Boehringer Ingelheim Investigational Site, Saint-Saulve

1160.85.3314A Boehringer Ingelheim Investigational Site, Toulouse

1160.85.3313A Boehringer Ingelheim Investigational Site, Toulouse Cédex 9

1160.85.3331A Boehringer Ingelheim Investigational Site, Vannes Cédex

1160.85.04924 Boehringer Ingelheim Investigational Site, Bad Homburg

1160.85.04926 Boehringer Ingelheim Investigational Site, Bayreuth

1160.85.04903 Boehringer Ingelheim Investigational Site, Berlin

1160.85.04931 Boehringer Ingelheim Investigational Site, Bochum

1160.85.04930 Boehringer Ingelheim Investigational Site, Breitenbrunn

1160.85.04923 Boehringer Ingelheim Investigational Site, Chemnitz

1160.85.04947 Boehringer Ingelheim Investigational Site, Erlangen

1160.85.04945 Boehringer Ingelheim Investigational Site, Fürth

1160.85.04912 Boehringer Ingelheim Investigational Site, Garmische-Partenkirchen

1160.85.04922 Boehringer Ingelheim Investigational Site, Gelnhausen

1160.85.04917 Boehringer Ingelheim Investigational Site, Gelsenkirchen

1160.85.04949 Boehringer Ingelheim Investigational Site, Günzburg

1160.85.04927 Boehringer Ingelheim Investigational Site, Hachenburg

1160.85.04910 Boehringer Ingelheim Investigational Site, Hamburg

1160.85.04906 Boehringer Ingelheim Investigational Site, Hanover

1160.85.04920 Boehringer Ingelheim Investigational Site, Hof

1160.85.04916 Boehringer Ingelheim Investigational Site, Kamp-Linfort

1160.85.04939 Boehringer Ingelheim Investigational Site, Kassel

1160.85.04929 Boehringer Ingelheim Investigational Site, Koblenz

1160.85.04909 Boehringer Ingelheim Investigational Site, Landstuhl

1160.85.04944 Boehringer Ingelheim Investigational Site, Lubin

1160.85.04935 Boehringer Ingelheim Investigational Site, Mainz

1160.85.04902 Boehringer Ingelheim Investigational Site, Marburg

1160.85.04934 Boehringer Ingelheim Investigational Site, Markgröningen

1160.85.04918 Boehringer Ingelheim Investigational Site, Marktheidenfeld

1160.85.04941 Boehringer Ingelheim Investigational Site, Merseburg

1160.85.04952 Boehringer Ingelheim Investigational Site, Minden

1160.85.04943 Boehringer Ingelheim Investigational Site, München

1160.85.04946 Boehringer Ingelheim Investigational Site, München

1160.85.04904 Boehringer Ingelheim Investigational Site, Nuremberg

1160.85.04913 Boehringer Ingelheim Investigational Site, Olsberg

1160.85.04932 Boehringer Ingelheim Investigational Site, Pfortzheim

1160.85.04901 Boehringer Ingelheim Investigational Site, Rosenheim

1160.85.04915 Boehringer Ingelheim Investigational Site, Rostock

1160.85.04928 Boehringer Ingelheim Investigational Site, Rostock

1160.85.04936 Boehringer Ingelheim Investigational Site, Rotenburg/Fulda

1160.85.04905 Boehringer Ingelheim Investigational Site, Schwarzenbruck

1160.85.04914 Boehringer Ingelheim Investigational Site, Sylt

1160.85.04933 Boehringer Ingelheim Investigational Site, Wertheim am Main

1160.85.04921 Boehringer Ingelheim Investigational Site, Wiesbaden

1160.85.04938 Boehringer Ingelheim Investigational Site, Wismar

1160.85.04907 Boehringer Ingelheim Investigational Site, Worms

1160.85.04940 Boehringer Ingelheim Investigational Site, Würzburg

1160.85.04948 Boehringer Ingelheim Investigational Site, Würzburg

1160.85.35301 Boehringer Ingelheim Investigational Site, Croom

1160.85.03911 Boehringer Ingelheim Investigational Site, Bari

1160.85.03905 Boehringer Ingelheim Investigational Site, Florence

1160.85.03904 Boehringer Ingelheim Investigational Site, Genova

1160.85.03906 Boehringer Ingelheim Investigational Site, Jesi (an)

1160.85.03914 Boehringer Ingelheim Investigational Site, Latina

1160.85.03901 Boehringer Ingelheim Investigational Site, Mantova

1160.85.03913 Boehringer Ingelheim Investigational Site, Ome (bs)

1160.85.03907 Boehringer Ingelheim Investigational Site, Roma

1160.85.03909 Boehringer Ingelheim Investigational Site, Torino

1160.85.03910 Boehringer Ingelheim Investigational Site, Vimercate (mi)

1160.85.4806 Boehringer Ingelheim Investigational Site, Gmina Świebodzin

1160.85.4805 Boehringer Ingelheim Investigational Site, Kościerzyna

1160.85.4804 Boehringer Ingelheim Investigational Site, Lodz

1160.85.4803 Boehringer Ingelheim Investigational Site, Otwock

1160.85.4802 Boehringer Ingelheim Investigational Site, Piekary Śląskie

1160.85.3404 Boehringer Ingelheim Investigational Site, Madrid

1160.85.3406 Boehringer Ingelheim Investigational Site, Madrid

1160.85.3405 Boehringer Ingelheim Investigational Site, Málaga

1160.85.3407 Boehringer Ingelheim Investigational Site, Pamplona

1160.85.3401 Boehringer Ingelheim Investigational Site, Valencia

1160.85.3402 Boehringer Ingelheim Investigational Site, Zaragoza

1160.85.4603 Boehringer Ingelheim Investigational Site, Kungälv

1160.85.4601 Boehringer Ingelheim Investigational Site, Motala

1160.85.4604 Boehringer Ingelheim Investigational Site, Sollefteå

1160.85.04405 Boehringer Ingelheim Investigational Site, Basildon

1160.85.04406 Boehringer Ingelheim Investigational Site, Gateshead

1160.85.04402 Boehringer Ingelheim Investigational Site, Halifax

1160.85.04404 Boehringer Ingelheim Investigational Site, London

1160.85.04403 Boehringer Ingelheim Investigational Site, Luton

1160.85.04401 Boehringer Ingelheim Investigational Site, Wigan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00846807 - Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery | Biotech Hunter | Biotech Hunter